Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Autoimmune Disorders

  Free Subscription


2 Diabetes
1 J Clin Endocrinol Metab
1 J Neuroimmunol
2 J Neurol
2 Mult Scler
1 Nat Rev Neurol
1 PLoS Med
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. VAN LUMMEL M, Buis DTP, Ringeling C, de Ru AH, et al
    Epitope Stealing as Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes.
    Diabetes. 2019 Jan 9. pii: db18-0501. doi: 10.2337/db18-0501.
    PubMed     Text format    

  2. SELVARAJAH D, Wilkinson ID, Fang F, Sankar A, et al
    Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study.
    Diabetes. 2019 Jan 7. pii: db18-0509. doi: 10.2337/db18-0509.
    PubMed     Text format     Abstract available

    J Clin Endocrinol Metab

  3. RADERMACHER LK, Ponto KA, Merkesdal S, Pomart V, et al
    Type I Diabetes Is The Main Cost Driver In Autoimmune Polyendocrinopathy.
    J Clin Endocrinol Metab. 2019 Sep 16. pii: 5570009. doi: 10.1210.
    PubMed     Text format     Abstract available

    J Neuroimmunol

  4. KURTUNCU M, Yilmaz V, Akcay HI, Turkoglu R, et al
    Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2019;337:577065.
    PubMed     Text format     Abstract available

    J Neurol

  5. PAOLICELLI D, Lucisano G, Manni A, Avolio C, et al
    Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
    J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09531.
    PubMed     Text format     Abstract available

  6. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
    J Neurol. 2019 Sep 17. pii: 10.1007/s00415-019-09535.
    PubMed     Text format     Abstract available

    Mult Scler

  7. MAGGI P, Absinta M, Sati P, Perrotta G, et al
    The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.
    Mult Scler. 2019 Sep 19:1352458519876031. doi: 10.1177/1352458519876031.
    PubMed     Text format     Abstract available

  8. PALOTAI M, Guttmann CR
    Brain anatomical correlates of fatigue in multiple sclerosis.
    Mult Scler. 2019 Sep 19:1352458519876032. doi: 10.1177/1352458519876032.
    PubMed     Text format     Abstract available

    Nat Rev Neurol

  9. DONG Y, Yong VW
    When encephalitogenic T cells collaborate with microglia in multiple sclerosis.
    Nat Rev Neurol. 2019 Sep 16. pii: 10.1038/s41582-019-0253.
    PubMed     Text format     Abstract available

    PLoS Med

  10. ENG SWM, Aeschlimann FA, van Veenendaal M, Berard RA, et al
    Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
    PLoS Med. 2019;16:e1002750.
    PubMed     Text format     Abstract available

    PLoS One

  11. OCANA GJ, Sims EK, Watkins RA, Ragg S, et al
    Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes.
    PLoS One. 2019;14:e0208456.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.